These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Acute toxicities experienced during simultaneous integrated boost intensity-modulated radiotherapy in head and neck cancers--experience from a north Indian regional cancer centre. Chakraborty S; Ghoshal S; Patil V; Oinam A; Suresh S Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):676-86. PubMed ID: 19748768 [TBL] [Abstract][Full Text] [Related]
8. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs. Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169 [TBL] [Abstract][Full Text] [Related]
9. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial. Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945 [TBL] [Abstract][Full Text] [Related]
10. Head and neck squamous cell carcinoma: optimizing the therapeutic index. Rosenthal DI; Blanco AI Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957 [TBL] [Abstract][Full Text] [Related]
12. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer. Rashad UM; Al-Gezawy SM; El-Gezawy E; Azzaz AN J Laryngol Otol; 2009 Feb; 123(2):223-8. PubMed ID: 18485252 [TBL] [Abstract][Full Text] [Related]
13. Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy. Tejwani A; Wu S; Jia Y; Agulnik M; Millender L; Lacouture ME Cancer; 2009 Mar; 115(6):1286-99. PubMed ID: 19170238 [TBL] [Abstract][Full Text] [Related]
14. Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: topical intrarectal versus subcutaneous application. Kouloulias VE; Kouvaris JR; Pissakas G; Mallas E; Antypas C; Kokakis JD; Matsopoulos G; Michopoulos S; Mystakidou K; Vlahos LJ Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):486-93. PubMed ID: 15890591 [TBL] [Abstract][Full Text] [Related]
15. The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial. Motallebnejad M; Akram S; Moghadamnia A; Moulana Z; Omidi S J Contemp Dent Pract; 2008 Mar; 9(3):40-7. PubMed ID: 18335118 [TBL] [Abstract][Full Text] [Related]
16. Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM study. Macann A; Fua T; Milross CG; Porceddu SV; Penniment M; Wratten C; Krawitz H; Poulsen M; Tang CI; Morton RP; Hay KD; Thomson V; Bell ML; King MT; Fraser-Browne CL; Hockey HU Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):572-9. PubMed ID: 24521675 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: a double-blind randomized study in head and neck cancer patients. Carvalho PA; Jaguar GC; Pellizzon AC; Prado JD; Lopes RN; Alves FA Oral Oncol; 2011 Dec; 47(12):1176-81. PubMed ID: 21911312 [TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: a report on acute normal tissue reactions. Suwinski R; Bankowska-Wozniak M; Majewski W; Sowa A; Idasiak A; Ziolkowska E; Windorbska W; Tarnawski R; Skladowski K; Maciejewski B Radiother Oncol; 2005 Oct; 77(1):58-64. PubMed ID: 16157401 [TBL] [Abstract][Full Text] [Related]
19. Cancer treatment-induced oral mucositis. Alterio D; Jereczek-Fossa BA; Fiore MR; Piperno G; Ansarin M; Orecchia R Anticancer Res; 2007; 27(2):1105-25. PubMed ID: 17465250 [TBL] [Abstract][Full Text] [Related]
20. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901. Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]